Provenonce Launches AI-Native GTM Platform, Deploys Semi-Sentient Agents for Business Execution
'Modern GTM teams are overwhelmed with noise but starving for clarity. We built this platform to turn signal into synchronized execution.'— Will O'Brien, co-founder and CEO, Provenonce, Inc.
SILICON VALLEY, CA, UNITED STATES, July 11, 2025 / EINPresswire.com / -- Provenonce, Inc. today announced the commercial launch of its AI-native go-to-market (GTM) platform—a modular automation system designed to help revenue teams streamline messaging, accelerate execution, and convert customer signals into action with unprecedented speed and clarity.
This milestone marks one year since Provenonce's AI pilot began and represents a major step forward in the company's mission to build intelligent systems that can scale with the complexity and pace of modern go-to-market operations.
Unlike legacy sales and marketing tools, the Provenonce platform is built to scale the signal—transforming fragmented data, shifting narratives, and cross-functional inputs into coherent workflows and strategic outputs.
'Modern GTM teams are overwhelmed with noise but starving for clarity,' said Will O'Brien, co-founder and CEO of Provenonce. 'We built this platform to turn signal into synchronized execution.'
Platform Performance and Momentum
During its pilot phase, Provenonce demonstrated powerful results across real-world GTM deployments:
– Generated and enriched over 10,000 qualified leads using adaptive outreach systems
– Reduced GTM content development cycles—from decks to outbound campaigns—by up to 75%
– Streamlined cross-functional collaboration for customers using HubSpot, Slack, and other CRM tools
The platform's modular design enables enterprise-ready deployment without requiring a rip-and-replace approach. Teams can integrate agents into their current workflows in hours—not quarters.
Modular Agents That Think in Context
At the heart of Provenonce is a system of semi-sentient agents—each designed to take on a key role in the go-to-market process:
– Sage, the systems strategist
– Minerva, the outreach engine
– Glyph, the emotional interface
– Logos, the visual architect
Each agent is contextually trained, blending AI capabilities with Provenonce's unique approach to memory, reasoning, and alignment with business intent. The result is a system that acts not just with precision—but with relevance.
'These aren't plug-ins or prompts,' added O'Brien. 'They're specialized intelligences that operate in sync—understanding what to do, when, and why.'
Rolling Stone Feature
Provenonce was recently profiled in Rolling Stone for its vision of human-centered AI augmentation:
'Just like the drum machine is a tool for musicians... Provenonce enhances—not replaces—the job of an individual or corporate marketing team.'
From Virtual Events to AI Execution
Founded in 2021, Provenonce originally launched Provenonce Summits, a virtual event platform used by organizations including Tony Robbins, Black Lab X, EPX, and ICOI. As generative AI matured, the company evolved from immersive environments to intelligent automation—transforming its infrastructure into a GTM execution engine.
Provenonce now delivers a unified solution for teams navigating lead prioritization, content generation, strategic messaging, and proposal orchestration—all grounded in an AI-native architecture.
Leadership and Vision
Will O'Brien, co-founder and CEO, previously served in executive roles at BitGo and Big Fish Games, and is a prolific angel investor and advisor with multiple unicorns. Provenonce reflects his vision of systems that blend cognition, clarity, and commercial scale.
The company is currently expanding customer deployments, developing channel partnerships, and actively onboarding growth-stage and enterprise teams seeking faster time-to-market with less manual overhead.
Provenonce has attracted investors across AI, web3, and enterprise SaaS, including Lemniscap, CitizenX, Delphi Ventures, and Tony Robbins' venture firm.
Get In Touch
Provenonce is now offering platform access to qualified customers and partners.
To request a demo or learn more, visit provenonce.ai.
About Provenonce
Provenonce, Inc. is an AI-native software company helping businesses accelerate go-to-market execution with modular, context-aware intelligence systems. Headquartered in Silicon Valley, Provenonce's agent-based platform enables customers to scale lead generation, messaging, and revenue workflows without losing clarity or strategic control.
Press Contact:
press@ provenonce.co
provenonce.ai | provenonce.co
Will O'Brien
Provenonce, Inc.
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
33 minutes ago
- Business Upturn
Music Licensing, Inc. (OTC: SONG) Enters Retainer Agreement with PCAOB-Registered Audit Firm for Review of Semi-Annual 2025 Financial Statements
NAPLES, FL, July 23, 2025 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, a diversified holding company and the fifth public performance rights organization (PRO) established in the United States, today announced that it has officially executed a retainer agreement with a Public Company Accounting Oversight Board (PCAOB)-registered audit firm. The agreement covers the review of the Company's semi-annual financial statements for the period ending June 30, 2025. This engagement represents a critical milestone in the Company's broader plan to adopt and maintain PCAOB-compliant financial reporting standards. It reflects a long-term commitment to enhancing transparency, supporting regulatory compliance, and upholding best practices in financial governance. The formal retention of a PCAOB-registered firm follows the Company's July 2, 2025 announcement regarding its intention to pursue annual audits and periodic reviews of financial statements. With the agreement now in place, the Company expects to proceed with the independent review process and release its semi-annual 2025 financials accordingly. The initiative is designed to strengthen the integrity of the Company's financial disclosures, build investor confidence, and support current and future capital markets activities. Music Licensing, Inc. licenses music to leading platforms and businesses globally, including TikTok, iHeartMedia, Triller, Napster, 7Digital, and Vevo. The Company holds an estimated 7.4% share of the U.S. public performance rights market and administers a catalog of over 2.5 million musical works. This includes works by high-profile recording artists as well as content generated through artificial intelligence (AI) platforms. The Company also maintains royalty interests in Listerine 'Mouthwash' Antiseptic and in a large portfolio of musical works performed by internationally recognized artists such as The Weeknd, Justin Bieber, Kanye West, Elton John, Rihanna, Lil Nas X, and others. This step positions the Company for continued operational growth, improved transparency, and future scalability in line with public company reporting standards. About Music Licensing, Inc. (OTC: SONG) ( About Music Licensing, Inc. (OTC:SONG) ( Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, is a diversified holding company and the fifth public performance rights organization (PRO) established in the United States. It is recognized under the federal registry of the United States government. The company licenses music to some of the most prominent platforms and businesses, including TikTok, iHeartMedia, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated 7.4% market share in the United States, representing a catalog of more than 2.5 million works by notable artists such as A$AP Rocky, Wiz Khalifa, Pharrell, Young Jeezy, Juelz Santana, Lil Yachty, MoneyBagg Yo, Larry June, Trae Pound, Sauce Walka, Trae Tha Truth, Sosamann, Soulja Boy, Lex Luger, Trauma Tone, Lud Foe, SlowBucks, Gunplay, OG Maco, Rich The Kid, Fat Trel, Young Scooter, Nipsey Hussle, Famous Dex, Boosie Badazz, Shy Glizzy, 2 Chainz, Migos, Gucci Mane, Young Dolph, Trinidad James, Chingy, Lil Gnar, 3OhBlack, Curren$y, Fall Out Boy, Money Man, Dej Loaf, Lil Uzi Vert, and many others, including works generated by artificial intelligence (AI). Additionally, Music Licensing, Inc. (OTC: SONG) holds royalty interests in Listerine 'Mouthwash' Antiseptic and a vast portfolio of musical works by globally renowned artists, including The Weeknd, Justin Bieber, Kanye West, Elton John, Mike Posner, blackbear, Lil Nas X, Lil Yachty, DaBaby, Stunna 4 Vegas, Miley Cyrus, Lil Wayne, XXXTentacion, BlueFace, The Game, Jeremih, Ty Dolla $ign, Eric Bellinger, Ne-Yo, MoneyBagg Yo, Halsey, Desiigner, DaniLeigh, Rihanna, and many others. Forward-Looking Statements: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person. Non-Legal Advice Disclosure: This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein. Non-Investment Advice Disclosure: This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication Contact: [email protected] SOURCE: Music Licensing, Inc Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Business Wire
2 hours ago
- Business Wire
Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased RxSight, Inc. ('RxSight' or the 'Company') (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the 'Class Period'). RxSight investors have until September 22, 2025 to file a lead plaintiff motion. Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action Share IF YOU SUFFERED A LOSS ON YOUR RXSIGHT, INC. INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT. You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at info@ by telephone at (310) 914-5007, or visit our website at What Happened? On July 8, 2025, after the market closed, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in LDD sales, LAL utilization, and overall revenue. The Company also lowered its full year 2025 guidance by approximately $42.5 million at the midpoint. The Company's Chief Executive Officer, Ronald Kurtz, disclosed that '[a]doption challenges over the last few quarters have been a primary reason for the LDD stall.' On this news, RxSight's stock price fell $4.84, or 37.8%, to close at $7.95 per share on July 9, 2025, on unusually heavy trading volume. What Is The Lawsuit About? The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the Company was experiencing 'adoption challenges' and/or structural issues resulting in declines in sales and utilization; (2) Defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Contact Us To Participate or Learn More: If you purchased RxSight securities, wish to learn more about this action, or have any questions concerning this announcement or your rights or interests with respect to these matters, please click HERE or contact us at: Law Offices of Frank R. Cruz 2121 Avenue of the Stars, Suite 800 Telephone: 310-914-5007 Email: info@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
2 hours ago
- Yahoo
DigitalOcean (DOCN) Launches GradientAI to Simplify GenAI Development
DigitalOcean Holdings, Inc. (NYSE:DOCN) is one of the top AI stocks with huge upside potential. On July 9, the company launched DigitalOcean GradientAI Platform. The managed service allows developers to build artificial intelligence applications by combining data with foundation models. A close-up of a person using a laptop with cloud solutions in the background. Previously known as GenAI Platform, the new service allows users to deploy generative AI capabilities without managing infrastructure. Developers can create AI applications that leverage foundation models from Anthropic, Meta, Mistral, and OpenAI on the new DigitalOcean platform. Additionally, it facilitates seamless integration with third-party APIs and agent routing, enabling connections with other GenAI agents. 'We built DigitalOcean GradientAI because generative AI can be complex – and DigitalOcean has always focused on making the complex simple,' said Bratin Saha, Chief Product and Technology Officer at DigitalOcean. DigitalOcean GradientAI Platform also comes with customization features such as guardrails designed to block sensitive information. Its launch comes as digital-native enterprises explore ways to integrate generative capabilities into their operations. DigitalOcean Holdings, Inc. (NYSE:DOCN) provides cloud infrastructure and tools to support AI development, focusing on simplifying the process for businesses. It also offers GPU-powered virtual machines, known as GPU Droplets, and a managed Kubernetes service for AI/ML workloads. While we acknowledge the potential of DOCN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best Chemical Stocks to Buy According to Billionaires and 7 Most Undervalued Pot Stocks To Buy According To Analysts. Disclosure: None. This article is originally published at Insider Monkey.